Home » INTEGRATED BIOPHARMA AND CITY OF HOPE CANCER CENTER ANNOUNCE CANCER TRIAL COLLABORATION
INTEGRATED BIOPHARMA AND CITY OF HOPE CANCER CENTER ANNOUNCE CANCER TRIAL COLLABORATION
Integrated Biotechnologies and the California-based City of Hope Cancer Center have entered into a collaboration research and development agreement to carry out a Phase I clinical trial of Phytosel, a plant-produced selenium product.
The study will attempt to determine whether the side-effects of two chemotherapeutic drugs can be lowered with high doses of Phytosel. It is expected to start in early 2006 and will take approximately one year to complete.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May